Non-Small Cell Lung Cancer Coverage from Every Angle
Advertisement
Advertisement

Roy S. Herbst, MD, PhD, on Lung Cancer: Update on Immunotherapy

Posted: Sunday, January 28, 2018

Roy S. Herbst, MD, PhD, of the Yale School of Medicine, discusses effective combination therapies and why some tumors are resistant to immunotherapy.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.